Search results for

Biologic drugs, often made with the help of living organisms, are especially lucrative because they have scant competition from biosimilars, drugs akin to generics. It's a different story in Europe.

Expect more aggressive regulatory action from the Trump administration while skirmishes continue in Congress and statehouses across the U.S. Many of these policies will ultimately land in court.

If implanted medical devices fail, patients and their insurers usually have to pay for repairs. That financial responsibility falls to them even when the problems were solely with the devices.

As the number of people who inject drugs and share needles has soared, the rate of infection with hep C has climbed, too. Yet many drug treatment patients aren't tested for the liver-damaging virus.

As hospital chains and insurers across the U.S squeeze one another, hoping to increase their market share, many patients are suddenly finding their preferred doctors and hospitals are out of network.

Some states have begun using Medicare reimbursement rates to recalibrate how they pay hospitals. If the gamble pays off, more private-sector employers could start doing the same thing.

As recent arrivals to the U.S. are released from detention with health problems ranging from diarrhea to gaping wounds, doctors who are trying to help, with little federal support, feel the strain.

The Trump administration's plan to force some Medicaid recipients to work to maintain benefits took another hit Wednesday when a U.S. district judge blocked such work rules in Kentucky and Arkansas.

Inspectors are citing facilities more often than during the Obama administration. But in response to industry prodding, the average fine is nearly a third lower, and the total assessed is down.

Unlike many private health plans, Medicare has no cap on out-of-pocket expenses for prescription drugs in Part D. As the cost of specialty drugs rises, some Medicare patients owe thousands of dollars.